Talis Biomedical Corporation (TLIS)
USD 1.74
(8.75%)
USD 1.74
(8.75%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 371 Thousand USD | 0.76% |
| 2022 | -4.73 Million USD | -80.81% |
| 2021 | -2.62 Million USD | -123.96% |
| 2020 | 10.93 Million USD | 175.03% |
| 2019 | 3.97 Million USD | 66.4% |
| 2018 | 2.39 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -195 Thousand USD | 58.6% |
| 2024 Q2 | -84 Thousand USD | 56.92% |
| 2023 Q4 | -471 Thousand USD | -772.86% |
| 2023 FY | -4.7 Million USD | 0.76% |
| 2023 Q1 | 117 Thousand USD | 105.26% |
| 2023 Q2 | 41 Thousand USD | -64.96% |
| 2023 Q3 | 70 Thousand USD | 70.73% |
| 2022 Q2 | -800 Thousand USD | 33.77% |
| 2022 FY | -4.73 Million USD | -80.81% |
| 2022 Q4 | -2.22 Million USD | -339.72% |
| 2022 Q3 | -506 Thousand USD | 36.75% |
| 2022 Q1 | -1.2 Million USD | -24.89% |
| 2021 Q4 | -967.21 Thousand USD | -35.13% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | -2.62 Million USD | -123.96% |
| 2021 Q2 | -579 Thousand USD | 0.0% |
| 2021 Q3 | -715.78 Thousand USD | -23.62% |
| 2020 Q3 | - USD | 0.0% |
| 2020 FY | 10.93 Million USD | 175.03% |
| 2020 Q4 | 10.93 Thousand USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2019 FY | 3.97 Million USD | 66.4% |
| 2019 Q4 | 1.5 Million USD | 0.0% |
| 2018 FY | 2.39 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 111.827% |
| Cerus Corporation | 86.4 Million USD | 99.571% |
| OrthoPediatrics Corp. | 111.25 Million USD | 99.667% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 49.833% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 95.514% |
| Inogen, Inc. | 126.69 Million USD | 99.707% |
| Spectral AI, Inc. | 7.88 Million USD | 95.292% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 105.628% |
| CVRx, Inc. | 33.03 Million USD | 98.877% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -508.197% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.924% |
| Venus Concept Inc. | 52.16 Million USD | 99.289% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 85.451% |
| Bioventus Inc. | 328.19 Million USD | 99.887% |
| BrainsWay Ltd. | 23.09 Million USD | 98.393% |
| Envoy Medical, Inc. | -473 Thousand USD | 178.436% |
| electroCore, Inc. | 13.22 Million USD | 97.195% |
| IceCure Medical Ltd | 1.3 Million USD | 71.462% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 106.132% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 883.759% |
| MaxCyte, Inc. | 36.54 Million USD | 98.985% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | 18.732% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -336.163% |
| PAVmed Inc | -3.96 Million USD | 109.35% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 106.764% |
| RxSight, Inc. | 53.76 Million USD | 99.31% |
| Sight Sciences, Inc. | 69.17 Million USD | 99.464% |
| SI-BONE, Inc. | 109.42 Million USD | 99.661% |
| TELA Bio, Inc. | 40.11 Million USD | 99.075% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 97.668% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 99.756% |
| LivaNova PLC | 771.25 Million USD | 99.952% |
| 908 Devices Inc. | 25.32 Million USD | 98.535% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.88% |
| Nemaura Medical Inc. | -1.47 Million USD | 125.129% |
| NeuroPace, Inc. | 48.12 Million USD | 99.229% |
| LENSAR, Inc. | 21.1 Million USD | 98.242% |
| Apyx Medical Corporation | 14.12 Million USD | 97.373% |
| Cutera, Inc. | 41.49 Million USD | 99.106% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 97.99% |
| BioSig Technologies, Inc. | 18 Thousand USD | -1961.111% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 99.64% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 97.275% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.958% |
| Axonics, Inc. | 274.55 Million USD | 99.865% |
| Outset Medical, Inc. | 29 Million USD | 98.721% |
| IRIDEX Corporation | 21.8 Million USD | 98.299% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 99.478% |
| IRadimed Corporation | 50.15 Million USD | 99.26% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -29.268% |
| INVO Bioscience, Inc. | 1.08 Million USD | 65.842% |
| Telesis Bio, Inc. | 16.95 Million USD | 97.811% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 99.671% |
| Varex Imaging Corporation | 256.9 Million USD | 99.856% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.774% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 191.379% |
| Pulmonx Corporation | 50.75 Million USD | 99.269% |
| Dynatronics Corporation | 7.63 Million USD | 95.141% |
| Modular Medical, Inc. | -768 Thousand USD | 148.307% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 93.313% |
| Semler Scientific, Inc. | 61.2 Million USD | 99.394% |
| InMode Ltd. | 411.34 Million USD | 99.91% |
| Bruker Corporation | 1.51 Billion USD | 99.976% |
| Cytosorbents Corporation | 22.39 Million USD | 98.343% |
| DexCom, Inc. | 2.28 Billion USD | 99.984% |
| Align Technology, Inc. | 2.71 Billion USD | 99.986% |
| Viveve Medical, Inc. | 620 Thousand USD | 40.161% |
| ZimVie Inc. | 290.38 Million USD | 99.872% |
| Movano Inc. | -158 Thousand USD | 334.81% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 99.661% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -336.163% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.899% |
| Profound Medical Corp. | 4.51 Million USD | 91.781% |
| Insulet Corporation | 1.15 Billion USD | 99.968% |
| enVVeno Medical Corporation | -546 Thousand USD | 167.949% |
| Surmodics, Inc. | 93.05 Million USD | 99.601% |
| iCAD, Inc. | 14.53 Million USD | 97.448% |
| Nuwellis, Inc. | 4.98 Million USD | 92.555% |
| Biotricity, Inc. | 8.35 Million USD | 95.56% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.888% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 203.326% |
| InspireMD, Inc. | 1.8 Million USD | 79.469% |
| PAVmed Inc. | -3.96 Million USD | 109.35% |
| BIOLASE, Inc. | 16.72 Million USD | 97.782% |
| Beyond Air, Inc. | -1.3 Million USD | 128.386% |
| FONAR Corporation | 45.14 Million USD | 99.178% |
| AxoGen, Inc. | 127.87 Million USD | 99.71% |
| Vivani Medical, Inc. | -357 Thousand USD | 203.922% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.81% |
| Inari Medical, Inc. | 434.56 Million USD | 99.915% |
| UFP Technologies, Inc. | 112.22 Million USD | 99.669% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -2863.495% |
| Tenon Medical, Inc. | 1.24 Million USD | 70.105% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 558.025% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 85.878% |
| AdaptHealth Corp. | 479.56 Million USD | 99.923% |
| Sintx Technologies, Inc. | 1.84 Million USD | 79.87% |
| NanoVibronix, Inc. | 1.53 Million USD | 75.862% |
| Quanterix Corporation | 70.64 Million USD | 99.475% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 191.379% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 97.361% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 99.297% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.759% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 91.669% |
| NeuroMetrix, Inc. | 3.94 Million USD | 90.601% |
| Hyperfine, Inc. | 4.75 Million USD | 92.201% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 99.653% |
| Biomerica, Inc. | 611 Thousand USD | 39.28% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 99.11% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 147.506% |
| Silk Road Medical, Inc | 127.08 Million USD | 99.708% |